Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Public Officials
- Remove English
- Remove Young Adults as Population Group
- Remove People with Substance Use or Abuse Problems as Population Group
- Remove People with Mental Health Problems as Population Group
- Remove Practitioner/Professional
- Remove Alcohol
- Remove Illegal Drugs
- Remove Opioids or Opiates
- Remove Marijuana
- Remove Cocaine
Main page content
Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health
Published: September 2017This report presents 2016 national estimates of use of alcohol, tobacco products, illicit drugs (such as, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives), substance use disorders, and substance use treatment among people 12 years of age and older. It Includes national estimates of any mental illness, serious mental illness, major depressive episode, use of mental health services and suicidal ideation among adults ages 18 or older and national estimates of major depressive episode, use of mental health services among adolescents aged 12 to 17. Trend information on these topics are also presented.
Published: June 2017This report presents national data about the prevalence of behavioral health conditions. This data includes the rate of serious mental illness, suicidal thoughts, substance use, and underage drinking. The report also highlights the percentages of those who seek treatment for these conditions. The state-level Barometers contain valuable insight into the behavioral health needs and the unique challenges faced by communities across the country. This analysis can help public health authorities and others determine the best ways of meeting behavioral health care needs and disparities among various communities.
Published: September 2014This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts. It reviews effective medications, including methadone, buprenorphine, and naltrexone. The guide also provides strategies to increase the use of MAT in drug court programs.
Published: September 2012This report examines trends in illicit substance use from 2010 to 2011 and from 2002 to 2011 among Americans 12 and older, comparing differences by age group and gender. It also discusses disparities in the need for specialized treatment versus those who actually receive it.